Earnings
BIO-B
675.25
0.00%
0.00
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
662.21M
328.91M
--
419.42M
--
--
0.00
--
622.25M
--
90.62M
16.42M
2.14B
693.51M
--
9.56B
--
291.92M
199.50M
--
86.72M
10.83B
12.97B
--
139.45M
0.00
--
--
--
362.33M
--
259.38M
--
--
--
230.91M
631.54M
12.26M
--
--
2.08B
372.10M
2.46B
3.09B
3000.00
429.38M
9.27B
-99.91M
--
--
9.88B
9.88B
12.97B
FY 2019-12-31
660.67M
453.97M
--
392.67M
--
--
0.00
--
554.01M
--
102.33M
16.50M
2.18B
701.21M
--
4.64B
--
264.13M
145.53M
--
79.64M
5.83B
8.01B
--
107.01M
0.00
--
--
--
287.10M
--
215.45M
--
--
--
156.86M
905.50M
13.58M
--
--
997.79M
336.94M
1.35B
2.25B
3000.00
410.02M
5.47B
-38.40M
--
--
5.76B
5.76B
8.01B
FY 2018-12-31
431.53M
413.27M
--
392.44M
--
--
0.00
--
583.82M
--
187.25M
15.18M
2.02B
508.69M
--
2.66B
--
219.77M
133.12M
--
70.30M
3.59B
5.61B
--
122.45M
0.00
--
--
--
264.47M
--
143.51M
--
--
--
184.34M
450.80M
438.94M
--
--
553.24M
147.77M
1.14B
1.59B
3000.00
394.34M
3.72B
-49.13M
--
--
4.02B
4.02B
5.61B
FY 2017-12-31
383.82M
371.15M
--
464.85M
--
--
0.00
--
594.80M
--
146.13M
15.88M
1.98B
493.50M
--
1.03B
--
506.07M
174.11M
--
94.95M
2.30B
4.27B
--
135.18M
0.00
--
--
--
--
--
171.63M
--
--
--
195.46M
502.70M
434.58M
--
--
222.21M
183.28M
840.07M
1.34B
3000.00
361.23M
1.83B
-217.00K
--
--
2.93B
2.93B
4.27B
FY 2016-12-31
456.26M
383.18M
--
372.35M
--
--
0.00
--
524.96M
--
91.01M
16.76M
1.84B
488.61M
--
830.79M
--
477.12M
161.61M
--
47.85M
2.01B
3.85B
--
133.11M
0.00
--
--
--
--
--
163.36M
--
--
--
174.51M
471.32M
434.19M
--
--
222.92M
135.32M
792.42M
1.26B
3000.00
332.91M
1.84B
-101.00K
--
--
2.59B
2.59B
3.85B

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out BIO-B latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze BIO RAD LABORATO recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.